Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond

Filiaciones

Goff D.A.:

The Ohio State University Wexner Medical Center, The Ohio State University College of Pharmacy, Columbus, OH, United States

Gauthier T.P.:

Baptist Health South Florida, Clinical Pharmacy Enterprise, Miami, FL, United States

Langford B.J.:

Public Health Ontario, Toronto, ON, Canada

Prusakov P.:

Nationwide Children's Hospital, Department of Pharmacy, Columbus, OH, United States

Ubaka Chukwuemka M.:

Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Enugu, Nsukka, Nigeria

Nwomeh B.C.:

Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, United States

Yunis K.A.:

Department of Pediatrics, Division of Neonatology, American University of Beirut, Beirut, Lebanon

Saad T.:

Pharmacy Department, American University of Beirut, Beirut, Lebanon

van den Bergh D.:

Division of Infectious Diseases & HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa

Villegas M.V.:

Universidad. Grupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, Colombia

Martinez N.:

Clinica Imbanaco, Cali, Colombia

Morris A.:

Sinai Health System-University Health Network Toronto, Toronto, ON, Canada

Ashiru-Oredope D.:

UK Health Security Agency, London, United Kingdom

Commonwealth Pharmacists Association, London, United Kingdom

Howard P.:

NHS England and NHS Improvement Quarry House, Leeds, United Kingdom

Sanchez P.J.:

Department of Pediatrics, Divisions of Neonatology and Pediatric Infectious Diseases, Nationwide Children's Hospital, Abigail Wexner Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Columbus, OH, United States